Drug-labels.com

Diprolene: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.05 %

Patient Medication Information: uses, side effects, how to take - Diprolene

What is DIPROLENE® used for?

DIPROLENE® is used in adults and children over 12 years of age on the skin for the relief of redness, swelling, heat, pain and itching caused by psoriasis and other skin problems.

How does DIPROLENE® work?

DIPROLENE® reduces inflammation and makes the blood vessels constrict to help relieve swelling, redness, heat, pain and itching.

What are the ingredients in DIPROLENE®?

Medicinal ingredient: betamethasone dipropionate

Non-medicinal ingredients: propylene glycol, propylene glycol stearate, white beeswax and white soft paraffin

DIPROLENE® comes in the following dosage forms:

Ointment; 0.05% W/W

Do not use DIPROLENE® if you:

  • are allergic to betamethasone dipropionate or any of the other ingredients of

    DIPROLENE®.

  • are allergic to a similar medication (corticosteroid).
  • have any infections like small pox, chicken pox, cold sores or genital herpes, fungal infections or tuberculosis of the skin.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take DIPROLENE®. Talk about any health conditions or problems you may have, including if you:

  • already use a similar medication (corticosteroid).
  • are pregnant or planning on becoming pregnant. It is not known if DIPROLENE® can harm your unborn baby. Your healthcare professional will decide whether giving you DIPROLENE® outweighs the potential risk to the unborn baby.

  • are breastfeeding or planning to breastfeed. It is not known whether DIPROLENE® can pass into your breastmilk. Your healthcare professional will decide whether you should stop breastfeeding or stop using DIPROLENE®.
  • have any infections.
  • have diseases of your skin that are caused by poor blood flow. An example is stasis dermatitis.
  • have increased pressure in your eyes (glaucoma).

Other warnings you should know about:

Do not use DIPROLENE® in or near your eyes.

Do not use DIPROLENE® under an air and water tight (occlusive) dressing.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take DIPROLENE®:

Usual dose: Apply a thin film once a day, in the morning, to cover the affected area. It may also be applied twice daily, in the morning and at night or as directed by your healthcare professional.

Overdose:

If you think you have taken too much DIPROLENE®, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed dose:

If you missed a dose of this medication, take it as soon as you remember. But if it is almost time for your next dose, skip the missed dose and continue with your next scheduled dose. Go back to the regular dosing schedule. Do not take two doses at the same time.

What are possible side effects from using DIPROLENE®?

These are not all the possible side effects you may feel when taking DIPROLENE®. If you experience any side effects not listed here, contact your healthcare professional.

Side effects may include:

  • Itching, dryness, stinging, burning, irritation
  • Increased redness
  • Blisters
  • Thinning of the skin
  • Swelling of the hair follicles
  • Stretch marks
  • Spider veins
  • Excessive hair growth
  • Change in skin pigmentation
  • Secondary infection
  • Skin rash around the mouth
  • Red, itchy rash caused by allergy to or contact with a substance (allergic contact dermatitis)
  • Softening or breaking down of skin due to moisture
  • Acne, rosacea
  • Heat rash
  • Hives
  • Blurred vision

Using DIPROLENE® can affect how your adrenal glands work. This can cause symptoms such as a round appearance of the face (moon face), stretch marks and slowed growth in children. If you develop any of these symptoms contact your healthcare professional.

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to
Health Canada by:
  • Visiting the Web page on Adverse Reaction Reporting
(https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-
canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store between 15°C and 30°C.

Keep out of the reach and sight of children.

If you want more information about DIPROLENE®:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada.html); the manufacturer’s website www.organon.ca, or by calling 1-844-820-5468.

Last revised: April 13, 2021

® N.V. Organon. Used under license.

© 2021 Organon Canada Inc. All rights reserved.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00629367

Revision date stated in the text: April 13, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Diprolene

Rx or OTC
Prescription (Rx)?
DIN 00629367
Schedule(s) PRESCRIPTION
Active ingredient(s) Betamethasone (betamethasone dipropionate) 0.05 %
Dosage form(s) Ointment
Route(s) of administration Topical
Drug class (WHO ATC)
  1. D Dermatologicals
    1. D07 Corticosteroids, dermatological preparations
      1. D07A Corticosteroid dermatological preparations, plain
        1. D07AC Corticosteroids, potent (group III)
          1. D07AC01 Betamethasone
Company ORGANON CANADA INC.
Current status Marketed
Current status date August 8, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.